CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 222,353	$ 224,680
Trade accounts receivable, net of allowances of $475 and $577 at March 31, 2025 and December 31, 2024, respectively	138,416	138,791
Deferred contract costs	28,513	27,958
Prepaid expenses	23,121	12,679
Other current assets	19,179	20,549
Total current assets	431,582	424,657
Equipment and leasehold improvements, net	20,711	19,321
Goodwill	891,050	882,593
Other intangible assets, net	139,446	147,823
Deferred contract costs, non-current	59,061	59,663
Other assets	46,782	46,172
Total assets	1,588,632	1,580,229
Current liabilities:
Accounts payable	20,273	18,405
Accrued liabilities	51,661	68,363
Income taxes payable	119	1,014
Deferred revenue	327,009	333,573
Total current liabilities	399,062	421,355
Deferred revenue, non-current	52,085	52,136
Deferred tax liability, net	5,132	5,180
Convertible senior notes, net	370,146	369,514
Other liabilities	14,985	16,061
Total liabilities	841,410	864,246
Commitments and contingencies (Note 7)
Stockholders’ equity:
Preferred stock, $0.001 par value, 50,000,000 shares authorized at March 31, 2025 and December 31, 2024; no shares issued and outstanding at March 31, 2025 and December 31, 2024	0	0
Common stock, $0.001 par value, 500,000,000 shares authorized at March 31, 2025 and December 31, 2024; 131,756,239 and 129,376,245 shares issued at March 31, 2025 and December 31, 2024, respectively; 131,756,239 and 129,332,030 shares outstanding at March 31, 2025 and December 31, 2024, respectively	125	125
Treasury stock, at cost; 0 and 44,215 shares at March 31, 2025 and December 31, 2024, respectively	0	(741)
Additional paid-in capital	1,292,918	1,269,264
Accumulated other comprehensive loss	(23,745)	(30,060)
Accumulated deficit	(522,076)	(522,605)
Total stockholders’ equity	747,222	715,983
Total liabilities and stockholders’ equity	$ 1,588,632	$ 1,580,229